Search research articles
Contact Us
Filters
Showing results (41-50 of 105) with videos related to
Page
of 11
Sort By:
International Journal of Molecular Sciences
|
October 14, 2022
In Vitro/In Vivo Translation of Synergistic Combination of MDM2 and MEK Inhibitors in Melanoma Using PBPK/PD Modelling: Part II
Jakub Witkowski, Sebastian Polak, Zbigniew Rogulski, et al.
The AAPS Journal
|
November 29, 2017
Real Patient and its Virtual Twin: Application of Quantitative Systems Toxicology Modelling in the Cardiac Safety Assessment of Citalopram
Nikunjkumar Patel, Barbara Wiśniowska, Masoud Jamei, et al.
Journal of Applied Toxicology : JAT
|
November 17, 2017
Drug interaction at hERG channel: In vitro assessment of the electrophysiological consequences of drug combinations and comparison against theoretical models
Barbara Wiśniowska, Bartosz Lisowski, Magdalena Kulig, et al.
International Journal of Molecular Sciences
|
November 11, 2022
In Vitro/In Vivo Translation of Synergistic Combination of MDM2 and MEK Inhibitors in Melanoma Using PBPK/PD Modelling: Part I
Jakub Witkowski, Sebastian Polak, Zbigniew Rogulski, et al.
Pharmaceutics
|
March 28, 2026
Exploring Tafamidis Effects Through PBPK-QSP Modelling
Seweryn Ulaszek, Bartek Lisowski, Barbara Wiśniowska, et al.
BMC Pharmacology & Toxicology
|
March 11, 2016
Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials
Barbara Wiśniowska, Zofia Tylutki, Gabriela Wyszogrodzka, et al.
Pharmaceutics
|
July 27, 2022
Quality Control Dissolution Data Is Biopredictive for a Modified Release Ropinirole Formulation: Virtual Experiment with the Use of Re-Developed and Verified PBPK Model
Olha Shuklinova, Przemysław Dorożyński, Piotr Kulinowski, et al.
International Journal of Molecular Sciences
|
February 11, 2023
In Vitro/In Vivo Translation of Synergistic Combination of MDM2 and MEK Inhibitors in Melanoma Using PBPK/PD Modelling: Part III
Jakub Witkowski, Sebastian Polak, Dariusz Pawelec, et al.
Database : the Journal of Biological Databases and Curation
|
October 8, 2022
An open-access data set of pig skin anatomy and physiology for modelling purposes
Laura Krumpholz, James F Clarke, Sebastian Polak, et al.
International Journal of Pharmaceutics
|
July 18, 2025
Physiologically based pharmacokinetic modelling of in vitro skin permeation of sunscreen actives under various experimental conditions
Yuri Dancik, Yanling Zhang, Krishna C Telaprolu, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 105) with videos related to
Sort By:
Page
of 11
International Journal of Molecular Sciences
|
October 14, 2022
In Vitro/In Vivo Translation of Synergistic Combination of MDM2 and MEK Inhibitors in Melanoma Using PBPK/PD Modelling: Part II
Jakub Witkowski, Sebastian Polak, Zbigniew Rogulski, et al.
The AAPS Journal
|
November 29, 2017
Real Patient and its Virtual Twin: Application of Quantitative Systems Toxicology Modelling in the Cardiac Safety Assessment of Citalopram
Nikunjkumar Patel, Barbara Wiśniowska, Masoud Jamei, et al.
Journal of Applied Toxicology : JAT
|
November 17, 2017
Drug interaction at hERG channel: In vitro assessment of the electrophysiological consequences of drug combinations and comparison against theoretical models
Barbara Wiśniowska, Bartosz Lisowski, Magdalena Kulig, et al.
International Journal of Molecular Sciences
|
November 11, 2022
In Vitro/In Vivo Translation of Synergistic Combination of MDM2 and MEK Inhibitors in Melanoma Using PBPK/PD Modelling: Part I
Jakub Witkowski, Sebastian Polak, Zbigniew Rogulski, et al.
Pharmaceutics
|
March 28, 2026
Exploring Tafamidis Effects Through PBPK-QSP Modelling
Seweryn Ulaszek, Bartek Lisowski, Barbara Wiśniowska, et al.
BMC Pharmacology & Toxicology
|
March 11, 2016
Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials
Barbara Wiśniowska, Zofia Tylutki, Gabriela Wyszogrodzka, et al.
Pharmaceutics
|
July 27, 2022
Quality Control Dissolution Data Is Biopredictive for a Modified Release Ropinirole Formulation: Virtual Experiment with the Use of Re-Developed and Verified PBPK Model
Olha Shuklinova, Przemysław Dorożyński, Piotr Kulinowski, et al.
International Journal of Molecular Sciences
|
February 11, 2023
In Vitro/In Vivo Translation of Synergistic Combination of MDM2 and MEK Inhibitors in Melanoma Using PBPK/PD Modelling: Part III
Jakub Witkowski, Sebastian Polak, Dariusz Pawelec, et al.
Database : the Journal of Biological Databases and Curation
|
October 8, 2022
An open-access data set of pig skin anatomy and physiology for modelling purposes
Laura Krumpholz, James F Clarke, Sebastian Polak, et al.
International Journal of Pharmaceutics
|
July 18, 2025
Physiologically based pharmacokinetic modelling of in vitro skin permeation of sunscreen actives under various experimental conditions
Yuri Dancik, Yanling Zhang, Krishna C Telaprolu, et al.
Page
of 11